Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:24:48 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - https://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.3701-0.0162-4.2262.4941200.38  0.39  0.3660.8194  0.328215:58:44Jun 0115 min RT 2¢

Recent Trades - Last 10 of 120
Time ETExPriceChangeVolume
15:58:44Q0.3701-0.0162465
15:58:43Q0.3701-0.01622,500
15:56:49Q0.377375-0.00892510
15:51:00Q0.3798-0.0065120
15:49:40Q0.37689-0.00941400
15:39:36Q0.37198-0.014322,500
15:39:35Q0.3705-0.015813,670
15:39:33Q0.3706-0.01572,500
15:39:31Q0.3706-0.0157600
15:39:28Q0.371-0.01533,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-01 07:02U:ELTPNews ReleaseElite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
2026-04-02 08:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
2026-02-17 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
2026-02-11 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
2025-11-14 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
2025-11-12 07:02U:ELTPNews ReleaseElite Pharmaceuticals Receives FDA Approval for Generic Requip XL(R)
2025-11-10 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025
2025-08-14 16:26U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information
2025-08-08 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025
2025-06-30 16:15U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information
2025-06-23 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025
2025-06-16 07:01U:ELTPNews ReleaseElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study